Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study.
Connolly SJ, Cybulsky I, Lamy A, Roberts RS, O'brien B, Carroll S, Crystal E, Thorpe KE, Gent M; Beta-Blocker Length Of Stay (BLOS) study. Connolly SJ, et al. Among authors: roberts rs. Am Heart J. 2003 Feb;145(2):226-32. doi: 10.1067/mhj.2003.147. Am Heart J. 2003. PMID: 12595838 Clinical Trial.
Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT).
Dorian P, Hohnloser SH, Thorpe KE, Roberts RS, Kuck KH, Gent M, Connolly SJ. Dorian P, et al. Among authors: roberts rs. Circulation. 2010 Dec 21;122(25):2645-52. doi: 10.1161/CIRCULATIONAHA.109.924225. Epub 2010 Dec 6. Circulation. 2010. PMID: 21135366 Clinical Trial.
Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH; Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Connolly SJ, et al. Among authors: roberts rs. JAMA. 2006 Jan 11;295(2):165-71. doi: 10.1001/jama.295.2.165. JAMA. 2006. PMID: 16403928 Clinical Trial.
259 results